Ocrevus is a prescription medication containing ocrelizumab, a monoclonal antibody. It is used to treat relapsing multiple sclerosis (RMS) in adults and primary progressive multiple sclerosis (PPMS) in adults.
Ocrevus works by targeting specific immune cells called B cells, which are thought to play a role in the damage to the myelin sheath that covers nerve fibers in people with multiple sclerosis. By reducing the number and activity of these B cells, Ocrevus may help to slow the progression of the disease and reduce the frequency and severity of relapses.
Additional Information:
- Active Ingredient: Ocrelizumab
- Dosage and Administration: Ocrevus is administered intravenously by a healthcare professional. The dose and frequency of administration will be determined by your doctor based on your individual needs.
- Side Effects: Common side effects of Ocrevus include infusion-related reactions, upper respiratory tract infection, headache, and nausea. Serious side effects can include infections, progressive multifocal leukoencephalopathy (PML), and malignancy.
- Precautions: Ocrevus should not be used in patients with active infections or those who have had a serious allergic reaction to ocrelizumab or any of its ingredients. It should also be used with caution in patients with a history of heart disease or stroke.
Storage:
- Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
- Do not freeze.
- Keep the vial in the outer carton to protect from light.
Manufacturer:
Roche
Note:
This product requires a prescription and should be used under the supervision of a qualified healthcare professional.
Disclaimer: The information provided here is for educational purposes only and should not replace professional medical advice. Always consult with a healthcare provider for medical guidance.
Reviews
There are no reviews yet.